Company: REVB
Filing Date: 2025-05-23
Form Type: S-1/A
Source: 0001213900-25-047104
Chunk: 78

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-23
Form: S-1/A
Chunk 78
---
 |     | $         |  49,769,969 |   |
| Accumulated deficit                                                                          |     | $                    | (42,556,723 | ) |     | $         | (42,556,723 | ) |
| Total stockholders’ equity (deficit)                                                         |     | $                    |   2,880,752 |   |     | $         |   7,216,159 |   |
| Total capitalization                                                                         |     | $                    |   2,880,752 |   |     | $         |   7,216,159 |   |

The foregoing pro forma as adjusted information is illustrative only, and our capitalization following the completion of this offering will be adjusted based on the actual public offering price and other terms of this offering determined at pricing. You should read this table together with our financial statements and the related notes appearing elsewhere in this prospectus and “Management’s discussion and analysis of financial condition and results of operations” sections of this prospectus. The above discussion and table is based on 963,796 shares of common stock outstanding on March 31, 2025, and excludes the following:

| ● | 97,880 shares of our common stock reserved for issuance under 
 our 2021 Equity Incentive Plan;                               |

| ● | 3 shares of our common stock reserved for the issuance of 
 Rollover RSUs;                                            |

| ● | 64 shares issuable upon exercise of stock options outstanding 
 under our 2021 Equity Incentive Plan;                         |

| ● | 7 shares of                                                                                  
 our common stock issuable upon the exercise of the Rollover Warrants, with an exercise price 
 of $45,070.73 per share;                                                                     |

| ● | 154 shares of our common stock issuable upon the exercise of the Class A 
 Common Stock Warrants, with an exercise price of $55,272.00 per share;   |

| ● | 497 shares of our common stock issuable upon the exercise                             
 of the Class B Common Stock Warrants, with an exercise price of $10,080.00 per share; |

| ● | 35 shares of our common stock issuable upon the exercise                                 
 of the Class B Placement Agent Warrants, with an exercise price of $12,600.00 per share; |

| ● | 194 shares of our common stock issuable upon the alternative                                                                        
 cashless exercise of the Class C Common